| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.14B | 16.04B | 15.63B | 17.37B | 15.54B | 12.46B |
| Gross Profit | 4.56B | 4.50B | 4.63B | 4.98B | 4.60B | 3.81B |
| EBITDA | 2.09B | 2.01B | 2.32B | 2.88B | 2.49B | 1.68B |
| Net Income | 577.62M | 591.47M | 1.04B | 1.33B | 1.26B | 727.41M |
Balance Sheet | ||||||
| Total Assets | 20.52B | 20.64B | 21.12B | 20.84B | 21.38B | 17.12B |
| Cash, Cash Equivalents and Short-Term Investments | 1.67B | 1.63B | 2.74B | 2.98B | 3.22B | 1.50B |
| Total Debt | 4.91B | 5.06B | 5.34B | 6.39B | 7.30B | 7.87B |
| Total Liabilities | 8.03B | 8.12B | 9.04B | 9.81B | 11.61B | 11.49B |
| Stockholders Equity | 12.30B | 12.33B | 12.04B | 11.00B | 9.77B | 5.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -752.22M | 850.13M | 675.39M | -627.90M | 205.81M |
| Operating Cash Flow | 0.00 | 1.67B | 2.04B | 2.62B | 1.27B | 1.77B |
| Investing Cash Flow | 0.00 | -2.34B | -1.07B | -1.82B | -1.84B | -1.33B |
| Financing Cash Flow | 0.00 | -450.68M | -1.20B | -1.04B | 2.29B | -164.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥200.50B | 22.33 | 11.00% | 2.20% | 6.75% | -0.16% | |
73 Outperform | ¥32.74B | 7.02 | ― | 2.62% | -10.49% | 981.82% | |
73 Outperform | ¥376.10B | 25.33 | ― | 1.30% | 8.44% | -0.89% | |
69 Neutral | ¥14.93B | 7.75 | ― | 1.87% | 14.95% | 11.72% | |
67 Neutral | ¥9.95B | 16.59 | ― | 1.36% | -1.34% | -26.52% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥2.28B | 104.52 | ― | 1.93% | -7.90% | -75.43% |